Tendersinfo Gulf

Filter Search

Healthcare and Medical

Location Summary Deadline
Germany Conclusion Of Non-exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Isosorbide Mononitrate, The Dosage Forms Ret/rek And Selected Strengths. 2026-04-22
Germany Conclusion Of Non-exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Methylphenidate In Selected Strengths And Dosage Forms. 2026-04-22
Germany Conclusion Of Non-exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Moxifloxacin In The Dosage Form Atr. 2026-04-22
Germany Conclusion Of Non-exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Trimethoprim + Sulfamethoxazole (co-trimoxazole) In The Dosage Form Tab. 2026-04-22
Germany Conclusion Of Non-exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V In The Active Ingredient Combination Risedronic Acid+ca+colecalciferol With The Atc Code: M05bb04. 2026-04-22
Germany Conclusion Of Non-exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Betaine. 2026-04-22
Germany Conclusion Of Non-exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Cefadroxil In The Dosage Form Tab. 2026-04-22
Germany Conclusion Of Non-exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Glatiramer Acetate In The Dosage Form Pen And From An Effective Strength Of 40 Mg/ml. 2026-04-22
Germany Conclusion Of Non-exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Ibuprofen In The Dosage Form Fta And From An Effective Strength Of 400 Mg As An Otc Medication. 2026-04-22
Germany Conclusion Of Non-exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Lercanidipine. 2026-04-22
Whats app